Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Stage IV Breast Cancer|Recurrent Breast Cancer
Interventions: DRUG: tamoxifen|DRUG: trastuzumab
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)